Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rodrigo Rafael Flores‐Mariñelarena"'
Autor:
Jeronimo Rafael Rodríguez-Cid, Saul Campos-Gomez, Vanessa García-Montes, Manuel Magallanes-Maciel, Rodrigo Rafael Flores-Mariñelarena, Valeria Michelle Fernández-Garibay, Iván Romarico González-Espinoza, Juan Paulo Ceja-García, Juan Carlos Cázarez-Price, Luis Martínez-Barrera, Leopoldo Barriguete-Parra, Carlos Jose Zuloaga-Fernandez, Roberto Kuri-Exsome, David Suárez-García, Jorge Ignacio Gonzalez-Villanueva, Noé Flores-Anaya, Jose Antonio Acevedo-Delgado, Alma Magdalena Astorga-Ramos, Raquel Gerson-Cwilich, Alberto Villalobos-Prieto, Claudia Rodríguez-Silva, Maria Fernanda Noriega-Iriondo, Leticia Vázquez-Cortés, Eusebio Perales-Rodríguez, Alicia Acosta-Espinoza, Yareni Perez-Lozano, Daniel Capdeville-García, Jorge Arturo Alatorre-Alexander
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 462-470 (2020)
PURPOSEThe LUME-Lung 1 study has brought consistent evidence of the effective use of nintedanib in lung adenocarcinoma as a second line of treatment; however, differences among ethnicities have been found in some studies.METHODSThis was a retrospecti
Externí odkaz:
https://doaj.org/article/9d217392ca9447fd9047653acf509678
Autor:
Anahí Castañeda‐Zárraga, Jerónimo Rafael Rodríguez‐Cid, Rodrigo Rafael Flores‐Mariñelarena, Héctor Trinidad‐Bibiano, José Fabián Martínez‐Herrera, Carla Paola Sánchez‐Ríos, Valeria Michelle Fernández‐Garibay, Jorge Arturo Alatorre‐Alexander, Luis Martínez‐Barrera, Patricio Javier Santillán‐Doherty, María Elisa Vega‐Memije
Publikováno v:
Thoracic Cancer, Vol 11, Iss 11, Pp 3243-3251 (2020)
Background A relationship between the EGFR signaling pathway expression in skin and the use of targeted cancer therapies has been previously demonstrated. Consistent evidence to support the use of skin biopsies as a surrogate for therapeutic evaluati
Externí odkaz:
https://doaj.org/article/35e073c0e5c649ada44cd7681096023f
Autor:
Julio César Garibay-Díaz, José Fabián Martínez-Herrera, Carla Paola Sánchez-Ríos, Julián Diaz-Rico, Jerónimo Rafael Rodríguez-Cid, Adriana Martinez-Camacho, Luis Manuel Martínez-Barrera, Jorge Arturo Alatorre-Alexander, Rodrigo Riera-Sala, Rodrigo Rafael Flores-Mariñelarena, Patricio Santillán-Doherty, Iván Romarico González-Espinoza, Anna Gozalishvili-Boncheva, Sonia Carrasco-Cara Chards, Vanessa García-Montes, Jordi Guzmán-Casta, Osvaldo Hernández-Flores
Publikováno v:
Lung Cancer Management
Background: Immunotherapy has demonstrated an improved overall survival (OS) and progression-free survival (PFS) as second-line treatment and subsequent lines compared with chemotherapy. Materials and methods: This was a retrospective review among ei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::011cb461c911084a20284a7f5cb9141d
http://europepmc.org/articles/PMC8369526
http://europepmc.org/articles/PMC8369526
Autor:
Juan Paulo Ceja-García, Manuel Magallanes-Maciel, Noé Flores-Anaya, Valeria Michelle Fernández-Garibay, Daniel Capdeville-García, Jerónimo Rafael Rodríguez-Cid, Carlos Jose Zuloaga-Fernandez, Jorge Ignacio Gonzalez-Villanueva, Vanessa García-Montes, Luis Manuel Martínez-Barrera, Jorge Arturo Alatorre-Alexander, Eusebio Perales-Rodríguez, Saúl Campos-Gómez, Leticia Vázquez-Cortes, Claudia Rodríguez-Silva, Alberto Villalobos-Prieto, Iván Romarico González-Espinoza, Leopoldo Barriguete-Parra, Alicia Acosta-Espinoza, José Antonio Acevedo-Delgado, Juan Carlos Cázarez-Price, David Suárez-García, Roberto Kuri-Exsome, Yareni Perez-Lozano, Raquel Gerson-Cwilich, Rodrigo Rafael Flores-Mariñelarena, Alma Magdalena Astorga-Ramos, Maria Fernanda Noriega-Iriondo
Publikováno v:
JCO Global Oncology
PURPOSE The LUME-Lung 1 study has brought consistent evidence of the effective use of nintedanib in lung adenocarcinoma as a second line of treatment; however, differences among ethnicities have been found in some studies. METHODS This was a retrospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80e2a1650e71514897659d1ba2a8416d
https://pubmed.ncbi.nlm.nih.gov/32196388
https://pubmed.ncbi.nlm.nih.gov/32196388
Autor:
Rodrigo Rafael Flores-Mariñelarena, Jorge Arturo Alatorre-Alexander, Javier Benjamin-Contreras, Orlando García-Acevedo, Jerónimo Rafael Rodríguez-Cid, María del Rosario Flores-Soto, Patricio Santillán-Doherty, Diana Bonilla-Molina, Luis Manuel Martínez-Barrera, Erika Sagrario Peña-Mirabal, Carla Paola Sánchez-Ríos
Publikováno v:
Journal of thoracic disease. 11(4)
Background: Overexpression of estrogen receptors in malignant pleural mesothelioma has shown an independent relation with a better prognosis of survival, and the use of selective estrogen receptor beta (ERβ) agonists increases the susceptibility to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e0dae05e93c383e9ff81e0a99e7d00d
https://pubmed.ncbi.nlm.nih.gov/31179088
https://pubmed.ncbi.nlm.nih.gov/31179088
Autor:
Carlos Cantú-Brito, Martin Lajous, Rodrigo Rafael Flores-Mariñelarena, Mario H Flores-Torres, Ruy Lopez-Ridaura, Andres Catzin-Kuhlmann
Publikováno v:
Circulation. 139
Introduction: Osteoarthritis is a growingly common joint disorder affecting older adults. It is characterized by chronic low-grade inflammation, a phenomenon by itself considered a cardiovascular risk factor. However, data on its potential impact on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99bebd1fe2b8fa4219b94746c5183476
https://doi.org/10.1161/circ.139.suppl_1.p302
https://doi.org/10.1161/circ.139.suppl_1.p302